JP2007531741A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007531741A5 JP2007531741A5 JP2007506363A JP2007506363A JP2007531741A5 JP 2007531741 A5 JP2007531741 A5 JP 2007531741A5 JP 2007506363 A JP2007506363 A JP 2007506363A JP 2007506363 A JP2007506363 A JP 2007506363A JP 2007531741 A5 JP2007531741 A5 JP 2007531741A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- hepatitis
- polypeptide
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55908104P | 2004-04-02 | 2004-04-02 | |
| US60/559,081 | 2004-04-02 | ||
| US60923804P | 2004-09-13 | 2004-09-13 | |
| US60/609,238 | 2004-09-13 | ||
| US63414404P | 2004-12-08 | 2004-12-08 | |
| US60/634,144 | 2004-12-08 | ||
| PCT/US2005/011450 WO2005097165A2 (en) | 2004-04-02 | 2005-04-04 | Il-28 and il-29 cysteine mutants for treating viral infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007531741A JP2007531741A (ja) | 2007-11-08 |
| JP2007531741A5 true JP2007531741A5 (https=) | 2008-03-06 |
| JP4896005B2 JP4896005B2 (ja) | 2012-03-14 |
Family
ID=34965116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007506363A Expired - Lifetime JP4896005B2 (ja) | 2004-04-02 | 2005-04-04 | Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (7) | US20050244423A1 (https=) |
| EP (1) | EP1750749A2 (https=) |
| JP (1) | JP4896005B2 (https=) |
| AU (1) | AU2005231476B2 (https=) |
| CA (1) | CA2558829C (https=) |
| IL (1) | IL177640A0 (https=) |
| WO (1) | WO2005097165A2 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60135393D1 (de) | 2000-06-30 | 2008-09-25 | Zymogenetics Inc | Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 |
| US7910313B2 (en) | 2001-04-20 | 2011-03-22 | Zymogenetics, Inc. | Cytokine protein family |
| US7038032B2 (en) | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| CA2503305A1 (en) | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| EP2251352A1 (en) | 2003-08-07 | 2010-11-17 | ZymoGenetics, L.L.C. | Homogeneous preparations of IL-28 and IL-29 |
| GB0405634D0 (en) | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
| JP4896005B2 (ja) * | 2004-04-02 | 2012-03-14 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法 |
| AU2006272937A1 (en) | 2005-07-20 | 2007-02-01 | Bristol-Myers Squibb Company | Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders |
| EP1912668A2 (en) * | 2005-07-20 | 2008-04-23 | ZymoGenetics, Inc. | Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| CA2625208A1 (en) | 2005-10-04 | 2007-04-12 | Zymogenetics, Inc. | Production and purification of il-29 |
| US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| US20090017108A1 (en) * | 2007-07-11 | 2009-01-15 | Alexander Yuzhakov | Liposome compositions for treatment of hepatitis C |
| KR101652767B1 (ko) * | 2008-04-04 | 2016-08-31 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Ｉｌ-28을 이용한 백신 및 면역치료제, 및 그를 사용하는 방법 및 조성물 |
| AU2009255994B2 (en) * | 2008-06-05 | 2014-07-17 | Bristol-Myers Squibb Company | Use of pegylated Type III Interferons for the treatment of hepatitis C |
| US20110263484A1 (en) * | 2008-10-13 | 2011-10-27 | Zymogenetics, Inc. | Single chain fc type iii interferons and methods of using same |
| US20100316608A1 (en) * | 2009-06-15 | 2010-12-16 | Vijayaprakash Suppiah | Method of Determining A Response To Treatment With Immunomodulatory Composition |
| CN102559737A (zh) * | 2011-12-13 | 2012-07-11 | 江南大学 | 一种人白细胞介素29的变异体及其制备方法 |
| AU2013323472B2 (en) * | 2012-09-28 | 2018-07-05 | Ellis KLINE | Glycosidase regimen for treatment of infectious disease |
| US10076512B2 (en) | 2014-05-01 | 2018-09-18 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
| US11311519B2 (en) | 2014-05-01 | 2022-04-26 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
| WO2016172342A1 (en) | 2015-04-21 | 2016-10-27 | Eiger Biopharmaceuticals, Inc. | Pharmaceutical compositions comprising lonafarnib and ritonavir |
| JP7674628B2 (ja) | 2016-02-19 | 2025-05-12 | イーアイティー・ファーマ・インコーポレイテッド | インターフェロンラムダによるデルタ型肝炎ウイルス感染の処置 |
| JP2023507501A (ja) | 2019-12-23 | 2023-02-22 | ヴェルサメブ アーゲー | 遺伝子の発現を同時に調節するための組成物及び方法 |
| EP4100047A4 (en) * | 2020-02-06 | 2024-03-13 | Eiger Biopharmaceuticals, Inc. | TREATMENT OF CORONAVIRUS INFECTION WITH INTERFERON LAMBDA |
| US20230201308A1 (en) * | 2020-02-06 | 2023-06-29 | Eiger Biopharmaceuticals, Inc. | Treatment of coronavirus infection with interferon lambda |
| CN117024530B (zh) * | 2023-07-20 | 2024-03-19 | 中国人民解放军空军军医大学 | 抗微生物肽Perceptide-TJ-2及其在制备广谱抗病毒药物中的用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8308534A1 (es) | 1980-01-08 | 1983-09-01 | Biogen Nv | Un metodo de producir un polipeptido que exhibe actividad inmunologica o biologica del interferon de leucocitos humanos. |
| US5206344A (en) * | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
| US6924270B2 (en) * | 2000-04-20 | 2005-08-02 | Schering Corporation | Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| DE60135393D1 (de) | 2000-06-30 | 2008-09-25 | Zymogenetics Inc | Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 |
| ATE549347T1 (de) | 2000-09-08 | 2012-03-15 | Schering Corp | Gene von säugetiere, und damit verbundene reagentien, methoden |
| EP1942187B1 (en) * | 2001-04-20 | 2010-09-22 | ZymoGenetics, L.L.C. | Cytokine protein family |
| US7038032B2 (en) * | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| WO2002092762A2 (en) | 2001-05-10 | 2002-11-21 | Immunex Corporation | Cytokine polypeptides |
| WO2003066002A2 (en) | 2002-02-08 | 2003-08-14 | University Of Medicine And Dentistry Of New Jersey | IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION |
| CN1659274A (zh) | 2002-04-19 | 2005-08-24 | 津莫吉尼蒂克斯公司 | 细胞因子受体 |
| CA2503305A1 (en) * | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| EP2251352A1 (en) * | 2003-08-07 | 2010-11-17 | ZymoGenetics, L.L.C. | Homogeneous preparations of IL-28 and IL-29 |
| JP4896005B2 (ja) * | 2004-04-02 | 2012-03-14 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法 |
| EP1912668A2 (en) | 2005-07-20 | 2008-04-23 | ZymoGenetics, Inc. | Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| AU2009255994B2 (en) | 2008-06-05 | 2014-07-17 | Bristol-Myers Squibb Company | Use of pegylated Type III Interferons for the treatment of hepatitis C |
-
2005
- 2005-04-04 JP JP2007506363A patent/JP4896005B2/ja not_active Expired - Lifetime
- 2005-04-04 WO PCT/US2005/011450 patent/WO2005097165A2/en not_active Ceased
- 2005-04-04 EP EP05735743A patent/EP1750749A2/en not_active Withdrawn
- 2005-04-04 CA CA2558829A patent/CA2558829C/en not_active Expired - Lifetime
- 2005-04-04 US US11/098,662 patent/US20050244423A1/en not_active Abandoned
- 2005-04-04 AU AU2005231476A patent/AU2005231476B2/en not_active Expired
-
2006
- 2006-08-22 IL IL177640A patent/IL177640A0/en unknown
-
2007
- 2007-09-20 US US11/858,699 patent/US20080075693A1/en not_active Abandoned
-
2008
- 2008-08-04 US US12/185,694 patent/US20090018080A1/en not_active Abandoned
-
2009
- 2009-05-21 US US12/470,336 patent/US20090263352A1/en not_active Abandoned
-
2010
- 2010-05-20 US US12/784,407 patent/US20110008280A1/en not_active Abandoned
-
2011
- 2011-07-26 US US13/190,628 patent/US8283448B2/en not_active Expired - Lifetime
-
2012
- 2012-09-07 US US13/606,176 patent/US8816053B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007531741A5 (https=) | ||
| ES2207830T3 (es) | Conjugados de polietilenglicol-interferon alfa para la terapia de infecciones. | |
| AR021876A1 (es) | Terapia de combinacion para vhc por induccion de ribavirina - interferon alfa pegilado | |
| JP2010503396A5 (https=) | ||
| US20130315952A1 (en) | Administration of interferon for prophylaxis against or treatment of pathogenic infection | |
| ATE377422T1 (de) | Nucleosid-analoga mit monozyklischen basischen carboxamidingruppen | |
| JP2001520238A5 (https=) | ||
| JP2008518943A5 (https=) | ||
| JP2003535043A5 (https=) | ||
| PL1778272T3 (pl) | Zastosowanie kombinacji cyklosporyny i pegylowanych interferonów do leczenia zapalenia wątroby typu C (HCV) | |
| JP2006506097A5 (https=) | ||
| JP2011519414A5 (https=) | ||
| JP2010513327A5 (https=) | ||
| JP2005525784A5 (https=) | ||
| JP2023510864A (ja) | グルカゴン、ｇｌｐ－１及びｇｉｐ受容体の全てに対して活性を有する三重活性体の持続型結合体の肺疾患の治療的使用 | |
| JP2008503207A5 (https=) | ||
| KR20070090002A (ko) | 인터페론―베타로 아시아 인구 집단의 ｃ형 간염 치료 | |
| Dahl et al. | In vitro inhibition of SARS virus replication by human interferons | |
| EP1797112B1 (en) | Inhibitors of hepatitits c virus | |
| CA2430115A1 (en) | Recombinant rsv virus expression systems and vaccines | |
| JP2008532995A (ja) | 組換え高効率複合インターフェロンの使用方法 | |
| JP2009504135A5 (https=) | ||
| JP2009529048A (ja) | 経口インターフェロンによる広域免疫および抗ウイルス遺伝子調節 | |
| JP2009232836A5 (https=) | ||
| JP2007516214A5 (https=) |